AzTrials
AzTrials

Low Back PainNCT03031158

Hip-spine Intervention for Older Adults With Chronic Low Back Pain

A study testing SFEX+H and SFEX in people with Low Back Pain, run by University of Delaware at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Low back pain (LBP) is extremely common in older adults and is associated with a host of negative consequences, including decreased physical function and increased healthcare utilization. Read more about this study

Who is it for?
Ages 60 to 85 years
Conditions the study is for
Low Back Pain
What is being tested?
SFEX+H and SFEX
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
1 Feb 2017to 13 Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 60-85
  • Low Back Pain for ≥ 3 months with pain of at least moderate intensity every day or almost every day that requires activity modification.
  • Presence of at least 1 hip impairment denoted by the American College of Rheumatology as potential indicators of hip osteoarthritis: hip pain, pain on hip internal rotation or morning stiffness of the hip of <60 minutes.

Who cannot join

  • Previous hip fracture repair or total hip replacement
  • Prominent component of radicular pain: CLBP with distal radiation below the knee
  • Known spinal pathology other than osteoarthritis: (e.g., a history of back surgery or recent trauma, spinal stenosis, vertebral compression fractures, ankylosing spondylitis, carcinoma metastatic to the spine)
  • Non-ambulatory, or severely impaired mobility (i.e., require the use of a wheelchair)
  • Folstein Mini-Mental State Examination score of <24
  • Severe visual or hearing impairment.
Show all 11Show fewer
  • Red flags indicative of a serious disorder underlying the LBP: Red flags that would require specialized medical attention include fever, significant unintentional weight loss, a sudden recent change in the character or intensity of pain, trauma that preceded the onset of pain, or signs and symptoms of caudae equinae (i.e. loss of sensation over saddle region, significant disturbances in bowel and bladder function).
  • Significant pain in parts of the body other than the back or acute LBP.
  • Acute, ongoing illness.
  • Inability to participate in the study for the full six months for any known reason.(i.e. moving away, extended vacation)
  • Received physical therapy for their LBP within in the last 3 months.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Delaware

    Newark, Delaware, 19713

Other trials in United States

About this study

Official title: Pilot Trial of a Hip-spine Intervention for Older Adults With a Primary Complaint of Low Back Pain

Low back pain (LBP) is extremely common in older adults and is associated with a host of negative consequences, including decreased physical function and increased healthcare utilization. Among older adults with LBP, hip impairments indicative of hip joint disease are more prevalent and associated with greater disability than among older adults without LBP. This study will investigate a novel intervention designed to improve LBP-related disability by combining a typical spine-focused exercise program with a hip-focused intervention.

Conditions
Low Back Pain
Being tested
SFEX+H, SFEX
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SFEX+HBehavioural

    Participants will receive an intervention consisting of heat to the low back, manual therapy to the hip (including movement of the hip by the therapist), hip-focused strengthening exercises and a trunk muscle training program including exercises for the abdominal and low back muscles. The intervention will be delivered twice weekly for 8 weeks.

  • SFEXBehavioural

    Participants will receive an intervention consisting of heat to the low back, manual therapy to the hip (including movement of the hip by the therapist) and a trunk muscle training program including exercises for the abdominal and low back muscles. The intervention will be delivered twice weekly for 8 weeks.

Study groups in NCT03031158
Study groupRoleWhat they receive
SFEX+HExperimentalParticipants will receive an intervention consisting of heat to the low back, manual therapy to the hip (including movement of the hip by the therapist), hip-focused strengthening exercises and a trunk muscle training program including exercises for the abdominal and low back muscles.
Receives: Behavioral: SFEX+H
SFEXActive comparatorParticipants will receive an intervention consisting of heat to the low back, manual therapy to the hip (including movement of the hip by the therapist) and a trunk muscle training program including exercises for the abdominal and low back muscles.
Receives: Behavioral: SFEX

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quebec Low Back Pain Disability Scale

    Measured: Change in disability score from pre-intervention to 20 weeks later

  2. Patient-Specific Functional Scale

    Measured: Change in pain-related function score from pre-intervention to 20 weeks later

Secondary outcomes (2)
  1. Walking Endurance as measured by the 6 minute walk test

    Measured: Change in walking endurance from pre-intervention to 20 weeks later

  2. Walking speed

    Measured: Change in walking endurance from pre-intervention to 20 weeks later

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2017 (estimated)
  2. Study start1 Feb 2017
  3. Primary completion13 Mar 2018
  4. Study completion13 Mar 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03031158
Sponsor's protocol ID
943328
Status last verified
Oct 2018
First submitted
23 Jan 2017
Last updated
9 Oct 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing SFEX+H and SFEX in people with Low Back Pain, run by University of Delaware at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quebec Low Back Pain Disability Scale (time frame: Change in disability score from pre-intervention to 20 weeks later). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in